Agenus | AGEN - Market Capitalization


Agenus reported $2.94B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Agenus USD 3.19B 3.06B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.76B 161M Aug/2026
CSL USD 60.19B 4.3B Aug/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Incyte USD 26.84B 4.19B Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Jiangsu Hengrui CNY 366.9B 29.67B Mar/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck EUR 62.37B 43.39B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Northwest Biotherapeutics USD 196M 136M Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026